These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8510320)

  • 21. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological types and drug-sensitivities of multiple strains of freshly isolated methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
    Jpn J Antibiot; 1991 Dec; 44(12):1376-85. PubMed ID: 1798072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus].
    Watanabe T; Kanno M; Sobu K; Takase Y; Yoshida T
    Jpn J Antibiot; 1995 Feb; 48(2):284-92. PubMed ID: 7745817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Survey of susceptibility of methicillin-resistant Staphylococcus aureus to antimicrobial agents in Hokusetsu General Hospital].
    Hijioka S; Nakata R; Yoshinami Y; Sugita K; Nishimura T
    Jpn J Antibiot; 2002 Dec; 55(6):764-70. PubMed ID: 12621730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
    Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
    Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
    Suzuki T; Fujita K; Nagamachi Y; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):634-9. PubMed ID: 8072171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus].
    Kondo S
    Jpn J Antibiot; 1994 Jun; 47(6):561-74. PubMed ID: 8072163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
    Araake M; Hara T; Miyata A; Tani M; Ogawa H
    Jpn J Antibiot; 2001 Feb; 54(2):69-78. PubMed ID: 11338680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study of methicillin-resistant Staphylococcus aureus (MRSA) infection in urological field].
    Ito Y; Tokuyama H; Yamada S; Komeda H; Takahashi Y; Okano M; Saitoh A; Deguchi T; Kanematsu M; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1993 Mar; 84(3):514-20. PubMed ID: 8515639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on the resistance of methicillin resistant Staphylococcus aureus to antimicrobial agents].
    Wang R; Nishioka K; Tanno Y
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):95-8. PubMed ID: 8070299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measurement of MICs on 16 antimicrobial agents for freshly isolated methicillin-resistant Staphylococcus aureus strains].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1990 Apr; 43(4):623-35. PubMed ID: 2381034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
    Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
    Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
    Miyata A; Araake M; Ogawa H; Hanaki H; Hiramatsu K
    Jpn J Antibiot; 2001 Jul; 54(7):372-81. PubMed ID: 11560056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Kono K; Takeda S; Tatara I; Arakawa K
    Jpn J Antibiot; 1994 Jun; 47(6):710-9. PubMed ID: 8072179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reliability of disc-diffusion susceptibility testing for arbekacin, vancomycin and teicoplanin against methicillin-resistant Staphylococcus aureus].
    Kouda M; Homma S; Udagawa I; Tamura K; Fukuhara J; Takeuchi M
    Jpn J Antibiot; 1999 Dec; 52(12):681-9. PubMed ID: 10695023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Aminoglycosides resistance of methicillin-resistant Staphylococcus aureus].
    Okamoto R; Okubo T
    Nihon Rinsho; 1992 May; 50(5):1036-41. PubMed ID: 1324330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
    Watanabe T; Sobu K; Takase Y; Kawabata T; Kanno M; Yoshida T
    Jpn J Antibiot; 1994 Jun; 47(6):701-9. PubMed ID: 8072178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genomic DNA fingerprinting of arbekacin-resistant MRSA by pulsed-field gel electrophoresis].
    Nonoyama M; Ida T; Hasobe T; Shimauchi C; Inoue M; Okamoto R; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):627-33. PubMed ID: 8072170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.